Drug Profile
Research programme: B219 leptin receptor - Interneuron
Alternative Names: B219 leptin receptor research programme - Amgen; B219 leptin receptor research programme - Interneuron; Research programme: B219 leptin receptor - AmgenLatest Information Update: 08 Jul 1999
Price :
$50
*
At a glance
- Originator Indevus Pharmaceuticals
- Developer Amgen; Indevus Pharmaceuticals
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haematological disorders; Immunological disorders; Obesity
Most Recent Events
- 08 Jul 1999 Discontinued-Preclinical for Haematological disorders in USA (Unknown route)
- 08 Jul 1999 Discontinued-Preclinical for Immunological disorders in USA (Unknown route)
- 08 Jul 1999 Discontinued-Preclinical for Obesity in USA (Unknown route)